Importer of Controlled Substances Registration: Mylan Pharmaceuticals, Inc., 20419 [2016-07946]
Download as PDF
<![CDATA[
20419
Federal Register / Vol. 81, No. 67 / Thursday, April 7, 2016 / Notices
Dated: March 28, 2016.
Louis J. Milione,
Deputy Assistant Administrator.
local laws, and reviewing the company’s
background and history.
Therefore, pursuant to 21 U.S.C.
952(a) and 958(a), and in accordance
with 21 CFR 1301.34, the above-named
company is granted registration as an
importer of the following basic classes
of controlled substances:
[FR Doc. 2016–07948 Filed 4–6–16; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Controlled substance
[Docket No. DEA–392]
Importer of Controlled Substances
Registration: Mylan Pharmaceuticals,
Inc.
ACTION:
Notice of registration.
Mylan Pharmaceuticals, Inc.
applied to be registered as an importer
of certain basic classes of controlled
substances. The Drug Enforcement
Administration (DEA) grants Mylan
Pharmaceuticals, Inc. registration as an
importer of those controlled substances.
SUPPLEMENTARY INFORMATION: By notice
dated December 4, 2015, and published
in the Federal Register on December 10,
2015, 80 FR 76709, Mylan
Pharmaceuticals, Inc., 3711 Collins
Ferry Road, Morgantown, West Virginia
26505 applied to be registered as an
importer of certain basic classes of
controlled substances. No comments or
objections were submitted for this
notice.
The DEA has considered the factors in
21 U.S.C. 823, 952(a) and 958(a) and
determined that the registration of
Mylan Pharmaceuticals, Inc. to import
the basic classes of controlled
substances is consistent with the public
interest and with United States
obligations under international treaties,
conventions, or protocols in effect on
May 1, 1971. The DEA investigated the
company’s maintenance of effective
controls against diversion by inspecting
and testing the company’s physical
security systems, verifying the
company’s compliance with state and
SUMMARY:
Amphetamine (1100) ....................
Lisdexamfetamine (1205) .............
Methylphenidate (1724) ................
Pentobarbital (2270) .....................
Oxycodone (9143) ........................
Hydromorphone (9150) ................
Hydrocodone (9193) .....................
Levorphanol (9220) ......................
Morphine (9300) ...........................
Oxymorphone (9652) ...................
Remifentanil (9739) ......................
Fentanyl (9801) ............................
Schedule
II
II
II
II
II
II
II
II
II
II
II
II
The company plans to import the
listed controlled substances in finished
dosage form (FDF) from foreign sources
for analytical testing and clinical trials
in which the foreign FDF will be
compared to the company’s own
domestically-manufactured FDF. This
analysis is required to allow the
company to export domesticallymanufactured FDF to foreign markets.
Dated: March 28, 2016.
Louis J. Milione,
Deputy Assistant Administrator.
[FR Doc. 2016–07946 Filed 4–6–16; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
VHG Labs DBA LGC
Standards Warehouse applied to be
registered as an importer of certain basic
classes of controlled substances. The
Drug Enforcement Administration
(DEA) grants VHG Labs DBA LGC
Standards Warehouse registration as an
importer of those controlled substances.
SUMMARY:
By notice
dated November 19, 2015, and
published in the Federal Register on
November 25, 2015, 80 FR 73830, VHG
Labs DBA LGC Standards Warehouse 3
Perimeter Road, Manchester, New
Hampshire 03103 applied to be
registered as an importer of certain basic
classes of controlled substances. No
comments or objections were submitted
for this notice.
The DEA has considered the factors in
21 U.S.C. 823, 952(a) and 958(a) and
determined that the registration of VHG
Labs DBA LGC Standards Warehouse to
import the basic classes of controlled
substances is consistent with the public
interest and with United States
obligations under international treaties,
conventions, or protocols in effect on
May 1, 1971. The DEA investigated the
company’s maintenance of effective
controls against diversion by inspecting
and testing the company’s physical
security systems, verifying the
company’s compliance with state and
local laws, and reviewing the company’s
background and history.
Therefore, pursuant to 21 U.S.C.
952(a) and 958(a), and in accordance
with 21 CFR 1301.34, the above-named
company is granted registration as an
importer of the following basic classes
of controlled substances:
SUPPLEMENTARY INFORMATION:
Importer of Controlled Substances
Registration: VHG Labs DBA LGC
Standards Warehouse
ACTION:
Notice of registration.
mstockstill on DSK4VPTVN1PROD with NOTICES
Controlled substance
Schedule
3-Fluoro-N-methylcathinone (3-FMC) (1233) ..............................................................................................................................................
Cathinone (1235) .........................................................................................................................................................................................
Methcathinone (1237) ..................................................................................................................................................................................
4-Fluoro-N-methylcathinone (4-FMC) (1238) ..............................................................................................................................................
Pentedrone (a-methylaminovalerophenone) (1246) ....................................................................................................................................
Mephedrone (4-Methyl-N-methylcathinone) (1248) ....................................................................................................................................
4-Methyl-N-ethylcathinone (4-MEC) (1249) ................................................................................................................................................
Naphyrone (1258) ........................................................................................................................................................................................
N-Ethylamphetamine (1475) ........................................................................................................................................................................
N,N-Dimethylamphetamine (1480) ..............................................................................................................................................................
Fenethylline (1503) ......................................................................................................................................................................................
4-Methylaminorex (cis isomer) (1590) .........................................................................................................................................................
Gamma Hydroxybutyric Acid (2010) ...........................................................................................................................................................
Methaqualone (2565) ..................................................................................................................................................................................
Mecloqualone (2572) ...................................................................................................................................................................................
JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl) indole) (6250) ...................................................................................................................
SR-18 (Also known as RCS-8) (1-Cyclohexylethyl-3-(2-methoxyphenylacetyl) indole) (7008) ..................................................................
VerDate Sep<11>2014
16:35 Apr 06, 2016
Jkt 238001
PO 00000
Frm 00101
Fmt 4703
Sfmt 4703
E:\FR\FM\07APN1.SGM
07APN1
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
]]>Agencies
[Federal Register Volume 81, Number 67 (Thursday, April 7, 2016)]
[Notices]
[Page 20419]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-07946]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Importer of Controlled Substances Registration: Mylan
Pharmaceuticals, Inc.
ACTION: Notice of registration.
-----------------------------------------------------------------------
SUMMARY: Mylan Pharmaceuticals, Inc. applied to be registered as an
importer of certain basic classes of controlled substances. The Drug
Enforcement Administration (DEA) grants Mylan Pharmaceuticals, Inc.
registration as an importer of those controlled substances.
SUPPLEMENTARY INFORMATION: By notice dated December 4, 2015, and
published in the Federal Register on December 10, 2015, 80 FR 76709,
Mylan Pharmaceuticals, Inc., 3711 Collins Ferry Road, Morgantown, West
Virginia 26505 applied to be registered as an importer of certain basic
classes of controlled substances. No comments or objections were
submitted for this notice.
The DEA has considered the factors in 21 U.S.C. 823, 952(a) and
958(a) and determined that the registration of Mylan Pharmaceuticals,
Inc. to import the basic classes of controlled substances is consistent
with the public interest and with United States obligations under
international treaties, conventions, or protocols in effect on May 1,
1971. The DEA investigated the company's maintenance of effective
controls against diversion by inspecting and testing the company's
physical security systems, verifying the company's compliance with
state and local laws, and reviewing the company's background and
history.
Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in
accordance with 21 CFR 1301.34, the above-named company is granted
registration as an importer of the following basic classes of
controlled substances:
------------------------------------------------------------------------
Controlled substance Schedule
------------------------------------------------------------------------
Amphetamine (1100)......................... II
Lisdexamfetamine (1205).................... II
Methylphenidate (1724)..................... II
Pentobarbital (2270)....................... II
Oxycodone (9143)........................... II
Hydromorphone (9150)....................... II
Hydrocodone (9193)......................... II
Levorphanol (9220)......................... II
Morphine (9300)............................ II
Oxymorphone (9652)......................... II
Remifentanil (9739)........................ II
Fentanyl (9801)............................ II
------------------------------------------------------------------------
The company plans to import the listed controlled substances in
finished dosage form (FDF) from foreign sources for analytical testing
and clinical trials in which the foreign FDF will be compared to the
company's own domestically-manufactured FDF. This analysis is required
to allow the company to export domestically-manufactured FDF to foreign
markets.
Dated: March 28, 2016.
Louis J. Milione,
Deputy Assistant Administrator.
[FR Doc. 2016-07946 Filed 4-6-16; 8:45 am]
BILLING CODE 4410-09-P
